SMTL ID : 6mo9.1 (2 other biounits)

N-terminal bromodomain of human BRD2 in complex with N-cyclopentyl-7-(3,5-dimethylisoxazol-4-yl)quinoline-5-sulfonamide inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

2 x JVY: N-cyclopentyl-7-(3,5-dimethyl-1,2-oxazol-4-yl)quinoline-5-sulfonamide(Non-covalent)

JVY.1: 3 residues within 4Å: Chain A: N.9, Q.12, L.119 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:N.9 Hydrogen bonds: A:Q.12, A:Q.12 JVY.2: 9 residues within 4Å: Chain A: W.29, P.30, F.31, V.35, L.40, L.42, N.88, I.94, M.97 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:W.29, A:W.29, A:P.30, A:F.31, A:L.40, A:L.40, A:L.42 Hydrogen bonds: A:N.88 Water bridges: A:Q.33, A:K.39

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sperandio, D. et al., Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor. Bioorg. Med. Chem. (2019)

Release Date

2019-01-23

Peptides

Bromodomain-containing protein 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bromodomain-containing protein 2

Related Entries With Identical Sequence